Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View - Discussing therapies in development for Homocystinuria including Pegtibatinase from Trevere and Pegtarviliase from Aeglea

Ticker(s): TVTX, AGLE

Who's the expert?

Institution: UT Southwestern

Assistant Professor at UT Southwestern Medical Center
Core director of the Human Genetics Clinical Laboratory
Primary clinical focus is the care of adolescents and adults with inborn errors of metabolism
Served as a PI or co-investigator for more than a dozen clinical trials and has published more than 25 articles, posters and abstracts

Interview Goal

This conversation will focus on the standard of care and landcape for Homocystinuria. We will get an expert's view on how promising the new therapies in develeopment from TVTX and AGLE are for this disorder.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.